Items Tagged ‘Other News Topics (not Types of Cancer)’

May 24, 2018

FDA Approves First non-opioid Treatment for Management of Opioid Withdrawal Symptoms in Adults

By

Encouraging more widespread innovation and development of safe and effective treatments for opioid use disorder remains top agency priority The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults. While Lucemyra may lessen the severity of withdrawal symptoms, it may […]

View full entry

Tags: General, lofexidine hydrochloride, Lucemyra, News, opiod addiction, Opiod withdrawl, Other News Topics (not Types of Cancer)


May 3, 2018

Lutathera Pepetide Receptor Radionuclide Therapy for NETs

By

CancerConnect News: Lutathera (lutetium Lu 177 dotatate) was recently approved for the treatment of neuroendocrine tumors (NETs) that typically occur in the pancreas and gastrointestinal tract. This is the first time a radioactive drug, or radiopharmaceutical, has been approved for the treatment of NETs. PRRT and NET NET is an abbreviation for Neuro-Endocrine Tumor. These […]

View full entry

Tags: General, News, Other News Topics (not Types of Cancer)


December 7, 2017

FDA and CMS Collaborate to Make Novel Cancer Biomarker Test Available

By

The U.S. Food and Drug Administration (FDA) has approved the F1CDx biomarker test designed to detect mutations in 324 genes and two genomic signatures in cancer patients. In a truly collaborative effort between the FDA and The Centers for Medicare & Medicaid Services (CMS) the latter proposed coverage of the F1CDx test under the new […]

View full entry

Tags: biomarker testing, CMS, foundation medicine, General, genomic testing, immunotherapy, KEYNOTE-028, News, Other News Topics (not Types of Cancer), PD-L1 positive, Precision Cancer Medicine, SCLS


September 21, 2015

Varubi Approved for Chemotherapy-Induced Nausea and Vomiting

By

The United States Food and Drug Administration (FDA) approved the agent Varubi (rolapitant) to be used to prevent delayed phase chemotherapy-induced nausea and vomiting (emesis). Chemotherapy-induced nausea and vomiting (CINV) is a common side effect of treatment with chemotherapy among cancer patients. It can become a serious side effect in that it can cause dehydration, electrolyte […]

View full entry

Tags: chemotherapy-induced, CINV, clinical trial, nausea, Other News Topics (not Types of Cancer), rolapitant, Varubi, vomiting


August 19, 2015

Smoking Cessation Drug Not Boosting Number of Smokers Who Quit

By

The introduction of a new prescription smoking-cessation aid, varenicline, in 2006 has had no significant impact on the rate at which Americans age 18 and older successfully quit smoking, according to a study led by researchers at University of California, San Diego School of Medicine. The findings, published online August 17 in Tobacco Control, suggest […]

View full entry

Tags: cessation aides, Chantix, General, Other News Topics (not Types of Cancer), quit smoking, tobacco control, varenicline


July 13, 2015

theGIConnection and the Inflammatory Bowel Disease Support Foundation Partner to Provide Crohn’s Disease and Ulcerative Colitis Patients with Virtual Support Community

By

July 13, 2015 – Fort Worth TX/Sun Valley ID —OMNI Health Media (OMNI) and the Inflammatory Bowel Disease Support Foundation (IBDSF) are pleased to announce a partnership with TheGIConnection that will both improve access to and increase support of patients and their families impacted by a diagnosis of Crohn’s disease or ulcerative colitis, collectively known as […]

View full entry

Tags: Chron's disease, General, Inflammatory Bowel Disease Support Foundation, online community, Other News Topics (not Types of Cancer), theGIConnection, ulcerative colitis